Arthneeti

Ipca Laboratories — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Ipca Laboratories holds 44.72% of the company. At a market capitalisation of ₹49.46k cr, that holding is worth ₹22.12k cr.

Promoter stake

44.72%

Value of holding

₹22.12k cr

Market cap

₹49.46k cr

Stake change

-1.57%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
46.29%—
Q4-2021
46.29%—
Q1-2022
46.29%—
Q2-2022
46.29%—
Q3-2022
46.29%—
Q4-2022
46.29%—
Q1-2023
46.29%—
Q2-2023
46.29%—
Q3-2023
46.29%—
Q4-2023
46.29%—
Q1-2024
46.30%—
Q2-2024
46.30%—
Q3-2024
46.30%—
Q4-2024
44.72%—
Q1-2025
44.72%—
Q2-2025
44.72%—
Q3-2025
44.72%—
Q4-2025
44.72%—
Q1-2026
44.72%—
Q2-2026
44.72%—
Q3-2026
44.72%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Ipca Laboratories's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.